JIN YOUNG SAKAI: Open Payments
NPI 1215706098 · SOUTHLAKE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,781 in 107 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,989 · 2025 $2,781
Food & beverage: $2,730Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $988 |
| Janssen Biotech, Inc. | 16 | $542 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $261 |
| Janssen Scientific Affairs, LLC | 1 | $129 |
| Braintree Laboratories, Inc. | 3 | $119 |
| Ipsen Biopharmaceuticals, Inc | 4 | $109 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $105 |
| Lilly USA, LLC | 4 | $77 |
| Regeneron Healthcare Solutions, Inc. | 3 | $76 |
| EVOKE PHARMA, INC. | 4 | $66 |
Products named: TREMFYA, RINVOQ, SKYRIZI, ENTYVIO, SUFLAVE, DUPIXENT, IQIRVO, EOHILIA.
Industry payments across TX — which companies pay providers there.
